These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16825256)

  • 1. Reducing cardiovascular disease in patients on peritoneal dialysis--is it possible?
    Zietse R; Marrón B
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii25-30. PubMed ID: 16825256
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.
    Van Biesen W; Verbeke F; Vanholder R
    Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633
    [No Abstract]   [Full Text] [Related]  

  • 3. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis.
    Segall L; Covic A
    Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221
    [No Abstract]   [Full Text] [Related]  

  • 5. V. Clinical algorithms on cardiovascular risk factors in renal patients.
    Nephrol Dial Transplant; 2000; 15 Suppl 5():123-54. PubMed ID: 11073285
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and mortality risk in patients treated by peritoneal dialysis.
    Zager PG; Rohrscheib MR
    Am J Kidney Dis; 2009 Jan; 53(1):9-11. PubMed ID: 19101397
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing cardiovascular disease in the dialysis patient.
    Baig SZ; Coats WC; Aggarwal KB; Alpert MA
    Adv Perit Dial; 2009; 25():147-54. PubMed ID: 19886337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease.
    Han SH; Choi HY; Kim DK; Moon SJ; Lee JE; Yoo TH; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
    Am J Nephrol; 2009; 29(2):129-35. PubMed ID: 18719346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent peritoneal dialysis catheter exit-site leak in a patient receiving maintenance immunosuppression with sirolimus.
    Perl J; Jassal SV; Bargman JM
    Clin Transplant; 2008; 22(5):672-3. PubMed ID: 18435788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What should nephrologists know about cardiac illnesses in patients on peritoneal dialysis?].
    Alonso Gómez AM
    Nefrologia; 2008; 28 Suppl 6():105-12. PubMed ID: 18957020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): a possible new marker of systemic endothelial dysfunction?
    Sánchez-Villanueva R; Bajo A; Del Peso G; Fernandez-Reyes MJ; González E; Romero S; Estrada P; Selgas R
    Nephrol Dial Transplant; 2009 Mar; 24(3):1009-14. PubMed ID: 18997161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From CANUSA to ADEMEX: do we need a new paradigm for definition of peritoneal dialysis adequacy?].
    Enia G
    G Ital Nefrol; 2006; 23(6):569-74. PubMed ID: 17173263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peritoneal dialysis in cirrhotic patients].
    De Vecchi AF
    G Ital Nefrol; 2009; 26(2):215-24. PubMed ID: 19382077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering early markers of cardiac disease by proteomics: avoiding (heart) failure!
    Gramolini AO; Emili A
    Expert Rev Proteomics; 2005 Oct; 2(5):631-4. PubMed ID: 16209642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example].
    Möhlenkamp S; Lehmann N; Moebus S; Schmermund A; Jöckel KH; Erbel R;
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2023-6. PubMed ID: 19777421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.